The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy

Journal of Cardiovascular Medicine

Volumn 16, Issue 9, 2015, Pages 597-602

  Vizzardi, Enrico ^a   Pina, Paolo Della ^a   Caretta, Giorgio ^a   Bonadei, Ivano ^a   Sciatti, Edoardo ^a   Lombardi, Carlo ^a   D'Aloia, Antonio ^a   Curnis, Antonio ^a   Metra, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Aortic distensibility; Aortic stiffness; Aortic strain; Echocardiography; Heart failure; Spironolactone

Indexed keywords

PLACEBO; POTASSIUM; SPIRONOLACTONE; MINERALOCORTICOID ANTAGONIST;

ADULT; AORTA VALVE; AORTIC DIMENSION; AORTIC DISTENSIBILITY; AORTIC STRAIN; ARTERIAL PRESSURE; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BLOOD VESSEL PARAMETERS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GYNECOMASTIA; HUMAN; HYPERKALEMIA; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASTALGIA; MIDDLE AGED; NEW YORK HEART ASSOCIATION CLASS; NONISCHEMIC CARDIOMYOPATHY; NONISCHEMIC DILATED CARDIOMYOPATHY; POTASSIUM BLOOD LEVEL; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; TREATMENT DURATION; AGED; AORTA; BLOOD PRESSURE; CARDIOMYOPATHY, DILATED; DRUG EFFECTS; ECHOGRAPHY; ELASTICITY; PATHOLOGY; PATHOPHYSIOLOGY;

AGED; AORTA; BLOOD PRESSURE; CARDIOMYOPATHY, DILATED; ELASTICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PROSPECTIVE STUDIES; SPIRONOLACTONE; VASCULAR STIFFNESS;

EID: 84942826596     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000102     Document Type: Article

References (32)

1. Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 2011; 57: 1511-1522.
2. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932-943.
3. Lage SG, Kopel L, Monachini MC, et al. Carotid arterial compliance in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 74: 691-695.
4. Eaton GM, Cody RJ, Binkley PF. Increased aortic impedance precedes peripheral vasoconstriction at the early stage of ventricular failure in the paced canine model. Circulation 1993; 88: 2714-2721.
5. Khan Z, Millard RW, Gabel M, Walsh RA, Hoit BD. Effect of congestive heart failure on in vivo canine aortic elastic properties. J Am Coll Cardiol 1999; 33: 267-272.
6. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 2002; 161: 1773-1781.
7. Wada T, Kodaira K, Fujishiro K, et al. Correlation of ultrasound-measured common carotid artery stiffness with pathological findings. Arterioscler Thromb 1994; 14: 479-482.
8. Blacher J, Amah G, Girerd X, et al. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens 1997; 10 (12 Pt 1): 1326-1334.
9. Lombes M, Oblin ME, Gasc JM, Baulieu EE, Farman N, Bonvalet JP. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res 1992; 71: 503-510.
10. Patrianakos AP, Parthenakis FI, Nyktari E, Malliaraki N, Karakitsos DN, Vardas PE. Central aortic stiffness in patients with nonischemic dilated cardiomyopathy: relationship with neurohumoral activation. J Card Fail 2009; 15: 665-672.
11. Lacolley P, Safar ME, Lucet B, Ledudal K, Labat C, Benetos A. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. J Am Coll Cardiol 2001; 37: 662-667.
12. Benetos A, Lacolley P, Safar ME. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1997; 17: 1152-1156.
13. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation 2002; 106: 2848-2853.
14. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
15. Kawasaki T, Sasayama S, Yagi S, Asakawa T, Hirai T. Noninvasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res 1987; 21: 678-687.
16. Patrianakos AP, Parthenakis FI, Karakitsos D, Nyktari E, Vardas PE. Proximal aortic stiffness is related to left ventricular function and exercise capacity in patients with dilated cardiomyopathy. Eur J Echocardiogr 2009; 10: 425-432.
17. Bonapace S, Rossi A, Cicoira M, et al. Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. Circulation 2003; 107: 1603-1608.
18. Ait-Oufella H, Collin C, Bozec E, et al. Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice. J Hypertens 2010; 28: 2336-2341.
19. Tropeano AI, Boutouyrie P, Pannier B, et al. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension 2006; 48: 80-86.
20. Cachofeiro V, Miana M, de Las Heras N, et al. Aldosterone and the vascular system. J Steroid Biochem Mol Biol 2008; 109: 331-335.
21. Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001; 345: 1689-1697.
22. Staessen J, Lijnen P, Fagard R, Verschueren LJ, Amery A. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J Endocrinol 1981; 91: 457-465.
23. de Souza F, Muxfeldt E, Fiszman R, Salles G. Efficacy of spironolactone therapy in patients with true resistant hypertension. Hypertension 2010; 55: 147-152.
24. Savoia C, Touyz RM, Amiri F, Schiffrin EL. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension 2008; 51: 432-439.
25. Davies J, Gavin A, Band M, Morris A, Struthers A. Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients. Br J Clin Pharmacol 2005; 59: 520-523.
26. Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol 2009; 54: 505-512.
27. McMurray JJ,AdamopoulosS,Anker SD, et al.ESCGuidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847.
28. Li X, Qi Y, Li Y, et al. Impact of mineralocorticoid receptor antagonists on changes in cardiac structure and function of left ventricular dysfunction: a meta-analysis of randomized controlled trials. CircHeart Fail2013;6: 156-165.
29. Vizzardi E, D'Aloia A, Giubbini R, et al. Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure. Am J Cardiol 2010; 106: 1292-1296.
30. Boutouyrie P, Lacolley P, Briet M, et al. Pharmacological modulation of arterial stiffness. Drugs 2011; 71: 1689-1701.
31. Mahmud A, Feely J. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens 2008; 21: 663-667.
32. Stefanadis C, Stratos C, Boudoulas H, Kourouklis C, Toutouzas P. Distensibility of the ascending aorta: comparison of invasive and noninvasive techniques in healthy men and in men with coronary artery disease. Eur Heart J 1990; 11: 990-996.